Posted: February 2017 By Lori Alexander, MTPW, ELS, MWC The closing plenary session at IASLC WCLC 2016 featured several highly regarded oncologists who have devoted the greater part of their […] Read more
By Cynthia L. Kryder, MS IASLC Lung Cancer News recently spoke with Kapil Dhingra, MD, of KAPital Consulting LLC in Sparta, New Jersey, about oncologic drug development and the challenges […] Read more
Next-generation sequencing (NGS) technology has revolutionized genomic and genetic research as it fulfills its potential to tailor the treatment of cancer patients in general and non-small cell lung cancer (NSCLC) […] Read more
The David A. Karnofsky Memorial Award from the American Society of Clinical Oncology (ASCO) recognizes oncologists who have made outstanding contributions to the research, diagnosis, or treatment of cancer. Dr. […] Read more
By Erik J. Mac Laren, PhD In 2015, the US Food and Drug Administration (FDA) approved an unprecedented 7 new drugs or new uses for drugs for patients with lung […] Read more
By Nicola M. Parry, DVM The 4th conference driven by the dynamic collaboration of the International Association for the Study of Lung Cancer (IASLC) and the American Association for Cancer […] Read more
Greetings. It is my privilege to introduce the IASLC Lung Cancer News (ILCN). I will be serving as Editor with the able assistance of my Associate Editors, Fabrice Barlesi, MD […] Read more